The present invention relates to immunosuppressant, process for theirproduction, their uses and pharmaceutical compositions containing them. Theinvention provides a novel class of compounds useful in the treatment orprevention of diseases or disorders mediated by lymphocyte interactions,particularly diseases associated with EDG receptor mediated signaltransduction.